General Information of the Compound
Compound ID |
CP0467217
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
1-(2-(2-bromophenyl)-1-phenylethyl)piperazine
Show/Hide
|
||||||||||||||||||
Synonyms |
1-(2-(2-bromophenyl)-1-phenylethyl)piperazine
CHEMBL378418
SCHEMBL5442011
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C18H21BrN2
|
||||||||||||||||||
Molecular Weight |
345.284
|
||||||||||||||||||
Canonical SMILES |
Brc1ccccc1CC(N1CCNCC1)c1ccccc1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C18H21BrN2/c19-17-9-5-4-8-16(17)14-18(15-6-2-1-3-7-15)21-12-10-20-11-13-21/h1-9,18,20H,10-14H2
Show/Hide
|
||||||||||||||||||
InChIKey |
KVNXQYJMNFSXRE-UHFFFAOYSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01026, Sodium-dependent noradrenaline transporter
Protein ID: PT00871, Sodium-dependent serotonin transporter
Clinical Information about the Compound